Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.
Kiniksa has an experienced team with a track record delivering therapies to patients. We have numerous product-candidates in both clinical and preclinical development across a range of debilitating diseases with significant unmet medical need.
Identify and rapidly develop product candidates with clear biology, validated mechanisms and the potential to deliver life-changing improvement to patients
clinical stage molecules
pivotal study in a rare, debilitating disease
pre-clinical molecules
discovery-stage targets
employees committed to helping patients